Skip to main content

Table 3 Characteristics of NICU patients comparing hypothermia therapy vs. non-hypothermia therapy groups

From: Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit

Variables Hypothermia therapy (n = 21) Non-hypothermia therapy (n = 68) P-value
Laboratory testing (7 days after intubation)
 CRP (mg/l), median (IQR) 57.53 (22.10–79.20) 58.76 (30.57–92.35) 0.565
 PCT (ng/ml), median (IQR) 0.13 (0.10–0.21) 0.17 (0.08–0.53) 0.431
 ALT (U/l), median (IQR) 35.43 (33.13–39.61) 44.50 (30.00–61.75) 0.889
 Scr (mmol/l), median (IQR) 50.00 (38.00–76.00) 58.50 (43.50–84.00) 0.214
 White blood cell count (× 109/l) 7.60 ± 2.31 10.10 ± 3.40 0.002
 Neutrophils (× 109/l) 6.22 ± 2.19 8.34 ± 3.04 0.004
 Lymph (× 109/l) 0.86 ± 0.48 1.13 ± 0.61 0.072
 Platelet (× 109/l) * 137.52 ± 63.20 180.60 ± 79.59 0.026
Use of sedative and analgesics (cumulative use time >  = 3d)
 Propofol or propofol medium and long chain fat emulsion 13 (61.9%) 49 (72.1%) 0.376
 Midazolam 17 (81.0%) 46 (67.6%) 0.258
 Remifentanil or fentanyl 18 (85.7%) 62 (91.2%) 0.755
  1. *The platelet count (7 days after intubation): mortality group (within 28 days) vs. alive group P = 0.006